These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 18693192)

  • 1. Is a step backwards in S-phase-targeted chemotherapy a step forward?
    Queiroz de Oliveira PE; Tomko RJ; Lazo JS
    Mol Interv; 2008 Jun; 8(3):137-40. PubMed ID: 18693192
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molecular mechanism of cell death induced by chemotherapeutic agents].
    Saya H
    Brain Nerve; 2009 Jul; 61(7):843-7. PubMed ID: 19618862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular mechanism regulating effect of anti-cancer agents].
    Saya H
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):1-5. PubMed ID: 19151557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Programmed cell death--significance for cancer etiology and treatment].
    Smeland EB
    Tidsskr Nor Laegeforen; 1992 May; 112(12):1567. PubMed ID: 1615504
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of senescence in the action of antitumor drugs.
    Gewirtz DA
    Curr Opin Investig Drugs; 2008 Jun; 9(6):562-4. PubMed ID: 18516754
    [No Abstract]   [Full Text] [Related]  

  • 6. DNA structure and integrity checkpoints during the cell cycle and their role in drug targeting and sensitivity of tumor cells to anticancer treatment.
    Skladanowski A; Bozko P; Sabisz M
    Chem Rev; 2009 Jul; 109(7):2951-73. PubMed ID: 19522503
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeting the cell death-survival equation.
    Benz EJ; Nathan DG; Amaravadi RK; Danial NN
    Clin Cancer Res; 2007 Dec; 13(24):7250-3. PubMed ID: 18094404
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell-cycle control in the face of damage--a matter of life or death.
    Clarke PR; Allan LA
    Trends Cell Biol; 2009 Mar; 19(3):89-98. PubMed ID: 19168356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cdc7 as a potential new target for cancer therapy.
    Ito S; Taniyami C; Arai N; Masai H
    Drug News Perspect; 2008 Nov; 21(9):481-8. PubMed ID: 19180266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selenocystine induces S-phase arrest and apoptosis in human breast adenocarcinoma MCF-7 cells by modulating ERK and Akt phosphorylation.
    Chen T; Wong YS
    J Agric Food Chem; 2008 Nov; 56(22):10574-81. PubMed ID: 18959417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics.
    Kinsella TJ
    Semin Oncol; 2009 Apr; 36(2 Suppl 1):S42-51. PubMed ID: 19393835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azidothymidine inhibits melanoma cell growth in vitro and in vivo.
    Humer J; Ferko B; Waltenberger A; Rapberger R; Pehamberger H; Muster T
    Melanoma Res; 2008 Oct; 18(5):314-21. PubMed ID: 18781129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetics of the p53 pathway, apoptosis and cancer therapy.
    Vazquez A; Bond EE; Levine AJ; Bond GL
    Nat Rev Drug Discov; 2008 Dec; 7(12):979-87. PubMed ID: 19043449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor of apoptosis (IAP) proteins: novel insights into the cancer-relevant targets for cell death induction.
    Fulda S
    ACS Chem Biol; 2009 Jul; 4(7):499-501. PubMed ID: 19588916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the DNA damage response in cancer.
    Ljungman M
    Chem Rev; 2009 Jul; 109(7):2929-50. PubMed ID: 19545147
    [No Abstract]   [Full Text] [Related]  

  • 16. A chemical inhibitor of Apaf-1 exerts mitochondrioprotective functions and interferes with the intra-S-phase DNA damage checkpoint.
    Mondragón L; Galluzzi L; Mouhamad S; Orzáez M; Vicencio JM; Vitale I; Moure A; Messeguer A; Perez-Paya E; Kroemer G
    Apoptosis; 2009 Feb; 14(2):182-90. PubMed ID: 19152031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitive effect of 3-bromopyruvic acid on human breast cancer MCF-7 cells involves cell cycle arrest and apoptotic induction.
    Liu XH; Zheng XF; Wang YL
    Chin Med J (Engl); 2009 Jul; 122(14):1681-5. PubMed ID: 19719971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death.
    Chari NS; Pinaire NL; Thorpe L; Medeiros LJ; Routbort MJ; McDonnell TJ
    Apoptosis; 2009 Apr; 14(4):336-47. PubMed ID: 19229632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of differentiation therapy].
    Hozumi M
    Gan To Kagaku Ryoho; 1993 Jun; 20(8):1006-8. PubMed ID: 8512331
    [No Abstract]   [Full Text] [Related]  

  • 20. Decrease in RelA phosphorylation by inhibiting protein kinase A induces cell death in NF-kappaB-expressing and drug-resistant tumor cells.
    Manna SK; Gangadharan C
    Mol Immunol; 2009 Apr; 46(7):1340-50. PubMed ID: 19128834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.